Trials / Completed
CompletedNCT06818968
A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)
A 2-period, Fixed-sequence, Open-label Study to Evaluate the Effect of Multiple Oral Doses of Diltiazem on the Single-dose Pharmacokinetics of MK-6916 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The goal of the study is to learn what happens to levels of MK-6916 in a healthy person's body over time. Researchers will compare what happens to MK-6916 in the body when it is given with or without another medicine called diltiazem.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-6916 | Oral administration |
| DRUG | Diltiazem | Oral administration |
Timeline
- Start date
- 2025-02-27
- Primary completion
- 2025-08-08
- Completion
- 2025-08-08
- First posted
- 2025-02-11
- Last updated
- 2025-08-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06818968. Inclusion in this directory is not an endorsement.